Your session is about to expire
← Back to Search
Behavioral Intervention
Cognitive Behavioral Therapy for Mental Health Issues in Deaf Individuals
N/A
Waitlist Available
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
18 years of age or older
Primary method of communication is ASL or PSE
Must not have
Unable to communicate with the researcher in ASL or PSE
Currently receiving behavioral health treatment for their symptoms.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights
Summary
This trial is testing an adapted version of Cognitive Behavioral Therapy designed for signing Deaf adults with symptoms of alcohol use disorder, PTSD, depression, anxiety, and/or insomnia. The goal is to see if this intervention is acceptable and feasible for use with this population and to collect feedback about the intervention.
Who is the study for?
This trial is for Deaf adults who primarily use ASL or PSE, are 18 or older, and have symptoms of alcohol use disorder, PTSD, depression, anxiety, or insomnia but aren't currently in treatment. Participants need video chat tech with internet and webcam. Those in immediate danger to themselves/others or already receiving treatment can't join.Check my eligibility
What is being tested?
The study tests an adapted Cognitive Behavioral Therapy (CBT-TS) for Deaf individuals with certain mental health issues. It's a single-arm pilot trial where participants receive the therapy and then report on their willingness to seek professional treatment along with changes in their mental health symptoms.See study design
What are the potential side effects?
Since CBT-TS is a form of therapy involving talking and behavior strategies rather than medication, it typically doesn't have physical side effects. However, discussing traumatic experiences may temporarily increase distress.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Select...
I primarily communicate using ASL or PSE.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I cannot communicate in American Sign Language or Pidgin Signed English.
Select...
I am currently in treatment for my mental health symptoms.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
mean change in attitudes about treatment
mean change in intention to seek treatment
mean change in perceived behavioral control about seeking treatment
+2 moreSecondary outcome measures
mean satisfaction with the intervention
proportion of eligible participant who enroll
proportion of participants eligible for the study
+2 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: All ParticipantsExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive Behavioral Therapy for Treatment Seeking (CBT-TS)
2023
N/A
~50
Find a Location
Who is running the clinical trial?
University of RochesterLead Sponsor
847 Previous Clinical Trials
535,355 Total Patients Enrolled
24 Trials studying Depression
8,742 Patients Enrolled for Depression
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am currently in treatment for my mental health symptoms.I cannot communicate in American Sign Language or Pidgin Signed English.I understand what this study involves.I am 18 years old or older.I primarily communicate using ASL or PSE.You have difficulty hearing and identify yourself as deaf or hard-of-hearing regardless of the degree of hearing loss.You are currently experiencing alcohol withdrawal symptoms that require medical evaluation.You consider yourself as someone who has difficulty hearing, whether partially or fully.
Research Study Groups:
This trial has the following groups:- Group 1: All Participants
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger